Navana Pharmaceuticals DSE:NAVANAPHAR Stock Report

Last Price


Market Cap







21 Jun, 2024


Company Financials

Navana Pharmaceuticals PLC


Market Cap: ৳9.8b

NAVANAPHAR Stock Overview

Navana Pharmaceuticals Limited engages in the manufacturing, marketing, and distribution of pharmaceutical and veterinary products in Bangladesh and internationally.

NAVANAPHAR fundamental analysis
Snowflake Score
Future Growth0/6
Past Performance5/6
Financial Health1/6

Navana Pharmaceuticals PLC Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Navana Pharmaceuticals
Historical stock prices
Current Share Price৳90.90
52 Week High৳122.40
52 Week Low৳78.30
11 Month Change-12.85%
3 Month Change2.25%
1 Year Change-20.05%
33 Year Changen/a
5 Year Changen/a
Change since IPO244.32%

Recent News & Updates

Recent updates

Shareholder Returns

NAVANAPHARBD PharmaceuticalsBD Market

Return vs Industry: NAVANAPHAR matched the BD Pharmaceuticals industry which returned -20.5% over the past year.

Return vs Market: NAVANAPHAR exceeded the BD Market which returned -24.2% over the past year.

Price Volatility

Is NAVANAPHAR's price volatile compared to industry and market?
NAVANAPHAR volatility
NAVANAPHAR Average Weekly Movement6.8%
Pharmaceuticals Industry Average Movement6.8%
Market Average Movement5.4%
10% most volatile stocks in BD Market7.6%
10% least volatile stocks in BD Market3.4%

Stable Share Price: NAVANAPHAR has not had significant price volatility in the past 3 months.

Volatility Over Time: NAVANAPHAR's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of BD stocks.

About the Company


Navana Pharmaceuticals Limited engages in the manufacturing, marketing, and distribution of pharmaceutical and veterinary products in Bangladesh and internationally. The company offers generic human health products, such as tablet, capsule, powder, cream, ointment, injection, eye and nasal drop, liquid, sachet, and oral solution; and animal health products, including vaccine, bolus, liquid, injection, water soluble powder, and premix. Navana Pharmaceuticals Limited was incorporated in 1986 and is based in Dhaka, Bangladesh.

Navana Pharmaceuticals PLC Fundamentals Summary

How do Navana Pharmaceuticals's earnings and revenue compare to its market cap?
NAVANAPHAR fundamental statistics
Market cap৳9.76b
Earnings (TTM)৳440.01m
Revenue (TTM)৳6.50b


P/E Ratio


P/S Ratio

Is NAVANAPHAR overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
NAVANAPHAR income statement (TTM)
Cost of Revenue৳3.51b
Gross Profit৳2.99b
Other Expenses৳2.55b

Last Reported Earnings

Mar 31, 2024

Next Earnings Date


Earnings per share (EPS)4.10
Gross Margin46.02%
Net Profit Margin6.77%
Debt/Equity Ratio105.9%

How did NAVANAPHAR perform over the long term?

See historical performance and comparison



Current Dividend Yield


Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.